InsidersTradesSigma
Track the 신라젠 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 신라젠 has logged 1 insider filings. Market capitalisation: €267.3bn. The latest transaction was reported on 5 March 2026 (Other). Among the most active insiders: 신라젠. The full history is free.
1
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 23,261 of 29,064 companies
30.6
score / 100
Value16
Quality45
FCF yld-9.8%
Earn yld-9.1%
EV/EBITDA·
ROE-21%
Gross mgn57%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 5 March 2026
关于 신라젠
신라젠 是一家专注于开发癌症治疗方法的生物技术公司。该公司在韩国交易所 (XKRX) 上市。